03Apr/13

Biogen Idec finalise l'achat de l'intégralité des droits et du contrôle de TYSABRI® – InformationHospitaliere.com

Biogen Idec finalise l’achat de l’intégralité des droits et du contrôle de TYSABRI®
InformationHospitaliere.com
Biogen Idec possède également le portefeuille le plus étendu du secteur pour la SEP avec des composés tels que le PLEGRIDY™ (peginterféron bêta-1a) ; le processus à haut rendement du daclizumab (DAC HYP) pour une administration sous-cutanée

and more »

03Apr/13

Biogen Idec completa l'acquisto di tutti i diritti e ottiene il pieno controllo di … – ANSA.it

Biogen Idec completa l’acquisto di tutti i diritti e ottiene il pieno controllo di
ANSA.it
Nel nostro settore industriale, Biogen Idec ha inoltre la pipeline più approfondita del settore per la SM, con composti che comprendono PLEGRIDY™ (peginterferone beta-1a); il processo ad alto rendimento Daclizumab (DAC HYP) per la somministrazione

and more »

03Apr/13

Biogen Idec Completes Purchase of Full Rights and Control of TYSABRI® – PharmiWeb.com (press release)

Biogen Idec Completes Purchase of Full Rights and Control of TYSABRI®
PharmiWeb.com (press release)
three principal products AVONEX® (interferon beta-1a) TYSABRI and RITUXAN® (rituximab) the importance of TYSABRI’s sales growth uncertainty of success in commercializing and developing other products product competition the occurrence of adverse

and more »

02Apr/13

Heart failure affects whites more – UPI.com


RedOrbit

Heart failure affects whites more
UPI.com
Heart failure is a disease of the aging, and on average, black men in America tend to have higher competing risks for death earlier in life,” Mark Huffman of Northwestern Medicine said in a statement. “Because competing risks are higher, which is
Lifetime Risks For Heart Failure Similar In Both White And Black RacesRedOrbit
Do Black Men Face Lower Risk of Heart Failure?MedPage Today

all 3 news articles »